These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 27853957)

  • 21. Salivary gland dysfunction and swallowing disorders.
    Stuchell RN; Mandel ID
    Otolaryngol Clin North Am; 1988 Nov; 21(4):649-61. PubMed ID: 3054718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired salivary dysfunction. Drugs and radiation.
    Fox PC
    Ann N Y Acad Sci; 1998 Apr; 842():132-7. PubMed ID: 9599303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of the salivary and gastrointestinal systems. II. Effects of salivary gland dysfunction on the gastrointestinal tract.
    Valdez IH; Fox PC
    Dig Dis; 1991; 9(4):210-8. PubMed ID: 1914220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Xerostomia.
    Delli K; Spijkervet FK; Kroese FG; Bootsma H; Vissink A
    Monogr Oral Sci; 2014; 24():109-25. PubMed ID: 24862599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease.
    Boyce HW; Bakheet MR
    J Clin Gastroenterol; 2005 Feb; 39(2):89-97. PubMed ID: 15681902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salivary gland dysfunction and xerostomia in Sjögren's syndrome.
    Jensen SB; Vissink A
    Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):35-53. PubMed ID: 24287192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of low-level light therapy on xerostomia related to hyposalivation: a systematic review and meta-analysis of clinical trials.
    Golež A; Frangež I; Cankar K; Frangež HB; Ovsenik M; Nemeth L
    Lasers Med Sci; 2022 Mar; 37(2):745-758. PubMed ID: 34409539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xerostomia/Salivary Gland Hypofunction: Diagnosis and Management.
    Zunt SL
    Compend Contin Educ Dent; 2018 Jun; 39(6):365-369; quiz 371. PubMed ID: 29847962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs or disease: evaluating salivary function in RA patients.
    Torres SR; Pedrazas CH; Correia MP; Azevedo MN; Zamprogno T; Silva A; Gonçalves LS; Papi JA
    Braz Oral Res; 2016 Oct; 30(1):e106. PubMed ID: 27737360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between regional idiopathic neuropathy and salivary involvement as the possible mechanism for oral sensory complaints.
    Granot M; Nagler RM
    J Pain; 2005 Sep; 6(9):581-7. PubMed ID: 16139777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xerostomia and hypofunction of the salivary glands in cancer therapy.
    Jensen SB; Pedersen AM; Reibel J; Nauntofte B
    Support Care Cancer; 2003 Apr; 11(4):207-25. PubMed ID: 12673459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salivary dysfunction caused by medication usage.
    Einhorn OM; Georgiou K; Tompa A
    Physiol Int; 2020 Jun; 107(2):195-208. PubMed ID: 32750027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment.
    Guchelaar HJ; Vermes A; Meerwaldt JH
    Support Care Cancer; 1997 Jul; 5(4):281-8. PubMed ID: 9257424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salivary gland performance in autoimmune diseases: review and meta-analysis.
    Moosavi MS; Barati H
    Acta Clin Belg; 2020 Feb; 75(1):19-25. PubMed ID: 30376766
    [No Abstract]   [Full Text] [Related]  

  • 35. Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction.
    Jensen SB; Mouridsen HT; Reibel J; Brünner N; Nauntofte B
    Oral Oncol; 2008 Feb; 44(2):162-73. PubMed ID: 17588802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xerostomia: clinical aspects and treatment.
    Cassolato SF; Turnbull RS
    Gerodontology; 2003 Dec; 20(2):64-77. PubMed ID: 14697016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of medical status, medications, and salivary flow rates in adults of different ages.
    Navazesh M; Brightman VJ; Pogoda JM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Feb; 81(2):172-6. PubMed ID: 8665310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical assessment of oral dryness is a significant predictor of salivary gland hypofunction.
    Longman LP; McCracken CF; Higham SM; Field EA
    Oral Dis; 2000 Nov; 6(6):366-70. PubMed ID: 11355268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An electro-stimulating oral splint for dry mouth treatment].
    Fedele S; Wolff A; Strietzel FP; Granizo López RM; Porter S; Konttinen YT
    Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):30-7, 73. PubMed ID: 19263865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A characterization of major salivary gland flow rates in the presence of medications and systemic diseases.
    Wu AJ; Ship JA
    Oral Surg Oral Med Oral Pathol; 1993 Sep; 76(3):301-6. PubMed ID: 8378045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.